abrdn Life Sciences Investors

07/18/2025 | Press release | Archived content

Q225 Commentary - abrdn Life Sciences Investors (HQL) (AA-180725-196289-6)

abrdn Life Sciences Investors published this content on July 18, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on October 16, 2025 at 07:18 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]